Definium Therapeutics, Inc. (DFTX) › Shareholders' EquityDefinium Therapeutics, Inc. (DFTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $4.78M2020: $75.87M2021: $151.66M2022: $150.92M2023: $78.13M2024: $241.45M2025: $332.33M$332.33M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$332.33M+37.6%2024$241.45M+209.0%2023$78.13M-48.2%2022$150.92M-0.5%2021$151.66M+99.9%2020$75.87M+1488.5%2019$4.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share